Alterations in patient plasma microRNA expression profiles following resection of metastatic melanoma
- PMID: 30132912
- PMCID: PMC6160327
- DOI: 10.1002/jso.25163
Alterations in patient plasma microRNA expression profiles following resection of metastatic melanoma
Abstract
Background and objectives: MicroRNAs (miRs) are noncoding RNAs that regulate protein translation and melanoma progression. Changes in plasma miR expression following surgical resection of metastatic melanoma are under-investigated. We hypothesize differences in miR expression exist following complete surgical resection of metastatic melanoma.
Methods: Blood collection pre- and post-surgical resection was performed in six individuals with solitary melanoma metastases. miR expression in extracted RNA was quantified using the NanoString nCounter Digital Analyzer.
Results: Pre- and post-surgical plasma samples contained 216 miRs with expression above baseline. Comparison of postsurgical to preresection samples revealed differential expression of 25 miRs: miR-let-7a, miR-let7g, miR-15a, miR-16, miR-22, miR-30b, miR-126, miR-140, miR-145, miR-148a, miR-150-5p, miR-191, miR-378i, miR-449c, miR-494, miR-513b, miR-548aa, miR-571, miR-587, miR-891b, miR-1260a, miR 1268a, miR-1976, miR-4268, miR-4454 (P < 0.05). Utilizing P < 0.0046 as a cutoff to control for one false positive among the 216 miRs revealed that postsurgical melanoma plasma samples had upregulation of miR-1260a (P = 0.0007) and downregulation of miR-150-5p (P = 0.0026) relative to pre-surgical samples.
Conclusions: Differential expression of miR-150-5p and miR-1260a is present in plasma following surgical resection of metastatic melanoma in this small sample (n = 6) of melanoma patients. Therefore, further investigation of these plasma miRs as noninvasive biomarkers for melanoma is warranted.
Keywords: NanoString; miR; miR-1260a; miR-150-5p; miRNA.
© 2018 Wiley Periodicals, Inc.
Figures


Similar articles
-
Plasma MicroRNA Levels Following Resection of Metastatic Melanoma.Bioinform Biol Insights. 2017 Feb 23;11:1177932217694837. doi: 10.1177/1177932217694837. eCollection 2017. Bioinform Biol Insights. 2017. PMID: 28469417 Free PMC article.
-
Global microRNA profiling of metastatic conjunctival melanoma.Melanoma Res. 2019 Oct;29(5):465-473. doi: 10.1097/CMR.0000000000000606. Melanoma Res. 2019. PMID: 30932942
-
Tissue microRNA expression profiling in hepatic and pulmonary metastatic melanoma.Melanoma Res. 2020 Oct;30(5):455-464. doi: 10.1097/CMR.0000000000000692. Melanoma Res. 2020. PMID: 32804708 Free PMC article.
-
Identification, Review, and Systematic Cross-Validation of microRNA Prognostic Signatures in Metastatic Melanoma.J Invest Dermatol. 2016 Jan;136(1):245-254. doi: 10.1038/JID.2015.355. J Invest Dermatol. 2016. PMID: 26763444 Review.
-
MicroRNA dysregulation in melanoma.Surg Oncol. 2016 Sep;25(3):184-9. doi: 10.1016/j.suronc.2016.05.017. Epub 2016 May 20. Surg Oncol. 2016. PMID: 27566021 Review.
Cited by
-
MCPIP1 ribonuclease can bind and cleave AURKA mRNA in MYCN-amplified neuroblastoma cells.RNA Biol. 2021 Jan;18(1):144-156. doi: 10.1080/15476286.2020.1804698. Epub 2020 Aug 20. RNA Biol. 2021. PMID: 32757706 Free PMC article.
-
A validation study for the utility of serum microRNA as a diagnostic and prognostic marker in patients with osteosarcoma.Oncol Lett. 2023 Apr 13;25(6):222. doi: 10.3892/ol.2023.13808. eCollection 2023 Jun. Oncol Lett. 2023. PMID: 37153065 Free PMC article.
-
A circular RNAs dataset landscape reveals potential signatures for the detection and prognosis of early-stage lung adenocarcinoma.BMC Cancer. 2021 Jul 6;21(1):781. doi: 10.1186/s12885-021-08293-7. BMC Cancer. 2021. PMID: 34229638 Free PMC article.
-
Potential Role of Selected miRNAs in the Pathogenesis of Autoimmune Thyroid Diseases in Children and Adolescents.Biomedicines. 2024 Mar 25;12(4):731. doi: 10.3390/biomedicines12040731. Biomedicines. 2024. PMID: 38672087 Free PMC article.
-
MicroRNA-587 Functions as a Tumor Suppressor in Hepatocellular Carcinoma by Targeting Ribosomal Protein SA.Biomed Res Int. 2020 Sep 5;2020:3280530. doi: 10.1155/2020/3280530. eCollection 2020. Biomed Res Int. 2020. PMID: 32964027 Free PMC article.
References
-
- Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277–300. - PubMed
-
- Pavri SN, Clune J, Ariyan S, Narayan D. Malignant Melanoma: Beyond the Basics. Plast Reconstr Surg. 2016;138:330e–340e. - PubMed
-
- Hengge UR, Wallerand A, Stutzki A, Kockel N. Cost-effectiveness of reduced follow-up in malignant melanoma. J Dtsch Dermatol Ges. 2007;5:898–907. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical